Minami Kentaro

ミナミケンタロウ | Minami Kentaro

Affiliation and department：
Job title： Pharmacist

Research keywords (3)：オートファジー , Anticancer agent resistance , molecular oncology

Research theme for competitive and other funds (6)：

2021 - 2024 オートファジー細胞死を標的とする新規肺腺癌治療薬の開発
2019 - 2021 Approach to regulatory mechanism of copy number variation the gene amplified.
2018 - 2021 gene amplification
2016 - 2020 Evaluation of moleclar bases for suppression of gene amplification
2015 - 2018 Molecular basis of cancer therapy targetting the gene amplification

Show all

Papers (32)：

Yusei Yamada, Madoka Fukaura-Nishizawa, Asami Nishiyama, Akira Ishii, Tatsuya Kawata, Aina Shirakawa, Mayuko Tanaka, Yuki Kondo, Toru Takeo, Naomi Nakagata, et al. Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann-Pick disease type C treatment. Clinical and Translational Medicine. 2023. 13. 8. e1350
Tatsuhiko Furukawa, Kentaro Mimami, Toshiyuki Nagata, Masatasu Yamamoto, Masami Sato, Akihide Tanimoto. Approach to Functions of BHLHE41/DEC2 in Non-Small Lung Cancer Development. International journal of molecular sciences. 2023. 24. 14
Tatsuhiko Furukawa, Sho Tabata, Kentaro Minami, Masatatsu Yamamoto, Kohichi Kawahara, Akihide Tanimoto. Metabolic reprograming of cancer as a therapeutic target. Biochimica et biophysica acta. General subjects. 2022. 1867. 3. 130301-130301
H. Koreeda, N. Yoshikawa, K. Minami, T. Yokota, H. Ochiai, R. Ikeda. Relationship between prognosis and timing of antimicrobial use in the treatment of severe flame burns: a single-centre retrospective study. Pharmazie. 2022
Yusei Yamada, Toru Miwa, Masaki Nakashima, Aina Shirakawa, Akira Ishii, Nanami Namba, Yuki Kondo, Toru Takeo, Naomi Nakagata, Keiichi Motoyama, et al. Fine-tuned cholesterol solubilizer, mono-6-O-α-D-maltosyl-γ-cyclodextrin, ameliorates experimental Niemann-Pick disease type C without hearing loss. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022. 155. 113698-113698

ｍore...

MISC (65)：

Yusei Yamada, Toru Miwa, Masaki Nakashima, Aina Shirakawa, Akira Ishii, Nanami Namba, Yuki Kondo, Toru Takeo, Naomi Nakagata, Keiichi Motoyama, et al. Fine-tuned cholesterol solubilizer, mono-6-O-α-D-maltosyl-γ-cyclodextrin, ameliorates experimental Niemann-Pick disease type C without hearing loss. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022. 155. 113698-113698
南謙太朗. みんなのギモンに答えます!くすりの「なぜ?」「これでいいの?」完全解決Q&A Q5 アスピリン喘息では,どんな人に注意が必要?. Expert Nurse. 2021. 37. 2
古川龍彦, 南謙太朗, 山本雅達, 河原康一. FARP1はインテグリンαvβ5に結合し,その発現上昇は進行胃がんの予後に関わる. 日本癌学会学術総会抄録集(Web). 2021. 80th
古川龍彦, 河原康一, 南謙太朗. FARP1 boosts CDC42 activity through Integrin αvβ5 and correlates unfavorable prognoses of the patients carrying advanced gastric cancer. 日本がん分子標的治療学会学術集会プログラム・抄録集. 2021. 25th
古川龍彦, 南健太朗, 河原康一, 新里能成. BHLHE41 suppress lung adeno carsinoma development. 日本がん分子標的治療学会学術集会プログラム・抄録集. 2020. 24th

ｍore...

Work history (2)：

2020/04 - 現在宮崎大学医学部附属病院薬剤部
2014/04 - 2020/03 鹿児島大学大学院医歯学総合研究科分子腫瘍学分野特任研究員

Awards (4)：

2023/08 - 第32回霧島神経薬理フォーラム霧島神経薬理フォーラム奨励賞
2019/11 - 第11回トランスポーター研究会九州部会優秀ポスター賞
2016/09 - 文部科学省科学研究費新学術領域研究「がん研究分野の特性等を踏まえた支援活動」がん若手研究者ワークショップ優秀ポスター賞
2011/12 - 鹿児島大学桜ヶ丘地区基礎研究発表会優秀発表賞

Association Membership(s) (7)：

日本臨床腫瘍薬学会 , 日本分子生物学会 , The Japanese Association for Molecular Target Therapy of Cancer , Japanese Cancer Association , The Japanese Pharmacological Society , The Pharmaceutical Society of Japan , 日本医療薬学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page